Celadon Pharmaceuticals
PublicCeladon Pharmaceuticals is now publicly traded
The data on this page reflects Celadon Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Mar 28, 2022
Last Round
Debt
Jun 11, 2025
Total Funding Raised
$18.54M
Company Overview
Celadon Pharmaceuticals has raised $18.54M. It was founded in 2018.
Celadon Pharmaceuticals is a pharmaceutical company that engages in the research, cultivation, manufacturing, and supply of cannabinoid-based medicines for the chronic pain market.
AI Layer
Non-AI
Celadon Pharmaceuticals Comparables
Compare Celadon Pharmaceuticals with similar companies based on industry and business-model similarity.
No comparables are published for Celadon Pharmaceuticals. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Celadon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 11, 2025 | ||||
| Private Placement | Sep 11, 2024 | ||||
| Private Placement | May 10, 2024 | ||||
| Private Placement | Dec 12, 2023 | ||||
| IPO | Mar 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celadon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seneca Partners | IPO |
Celadon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.